NICE guidance on stents

NICE has published its final draft guidance on the use of drug-eluting stents for the treatment of coronary artery disease (CAD).

The draft guidance recommends the use of drug-eluting stents (DES) for those patients who are at higher risk of needing further stents if a conventional bare-metal stent (BMS) were used instead. These patients have a coronary artery less than 3 mm in diameter, or the segment of the artery to be treated is longer than 15 mm.

The draft guidance also states that drug eluting stents should only be used if the price difference between it and a bare metal stent is no more than £300.

Latest Issues

EBME Expo 2025

Coventry Building Society Arena, UK
25th - 26th June 2025

AfPP Annual National Conference

University of Warwick
8th - 9th August 2025

Clinical Engineering Conference

Stansted Radisson Blu
23rd September 2025

Infection Prevention 2025

Brighton Centre, UK
29th - 30th September 2025